Trial of Eculizumab for HUS approved26th December 2015
The trial for the drug Eculizumab for HUS sufferers has been approved. The study is known as the ECUSTEC. The drug is currently being used by aHUS sufferers. The Charity welcomes the trial which will start in 2016 as it is hoped that it will help improve the outcome for sufferers of HUS. To date there has been no specific treatment.
The Charity is one of the co-applicants for the drug based on the fact that there has been no such treatments previously. Whilst only time will tell whether or not the drug will work, we can only hope that it will be beneficial long term for such sufferers. The trial will take several years to complete.
1 of 46
A recent news article in the Environmental Health News indicates the concerns the Chartered Institute of Environmental Health (CIEH) have over UK food safety being at risk, due to lack of staff. Food safety allocated posts supporte... ...read on
On the 29th December 2023 the FSA stated on their website “Chiltern Artisan recalls Chilli Sticks because of contamination with E. Coli. Chiltern Artisan has taken the precautionary step of recalling Chiltern Artisan Chilli Sticks because E. Coli has been fo... ...read on
Amy Douglas, Incident Director for Gastrointestinal Infections and Food Safety Division at UKHSA, said: "There have been at least 30 confirmed cases of this specific outbreak strain of STEC in the UK." - Link below. ... ...read on
The recall for Route des Terroirs is recalling Morbier Maison Monts & Terroirs Chalet De Vevy Raw Cows’ Milk Cheese because Shiga toxin-producing E.coli has been found in some batches of this product. This recall was announced today 25/12/2023. ... ...read on
Information Rights Team ... ...read on
1 of 46